Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov;2(4):100108.
doi: 10.1016/j.jcvp.2022.100108. Epub 2022 Sep 13.

Clinical performance of SARS-CoV-2 detection on the cobas Liat using water gargle samples

Affiliations

Clinical performance of SARS-CoV-2 detection on the cobas Liat using water gargle samples

Maxime Veillette et al. J Clin Virol Plus. 2022 Nov.

Abstract

Spring water gargle (SWG) is a suitable, non-invasive, alternative specimen for SARS-CoV-2 detection by RT-PCR. This study sought to evaluate the performance of the cobas Liat point-of-care system for the detection of SARS-CoV-2 in SWG samples. SWG samples and standard oral and nasopharyngeal swab (ONPS) were collected simultaneously from participants in a COVID-19 screening clinic, in November and December 2020. Both sample types were analyzed in parallel on the cobas Liat platform and with the Seegene Allplex 2019-nCoV assay. Among the 110 participants, 53% had compatible symptoms and 71% had a contact with a confirmed COVID-19 case. Only two (1.8%) individuals had neither symptoms nor contact. Amongst 110 paired samples, 25 (23%) were positive for SARS-CoV-2 on the cobas Liat for a least one sample type, with a kappa coefficient of 0.92. Agreement between the cobas Liat platform and the Seegene assay was also excellent (kappa coefficient values of 0.94 and 0.95). Two SWG samples failed to provide a positive result when their ONPS pair was positive, but their cycle threshold (Ct) values were >35 on the Seegene assay, reflecting a low viral load. Overall, the performance of the cobas Liat platform is excellent for the detection of SARS-CoV-2 in SWG samples in a high pre-test probability population.

Keywords: COVID-19; Gargle; SARS-CoV-2; cobas Liat.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Seegene Allplex 2019‐nCoV assay cycle threshold values distribution, by sample type. Ct: Cycle threshold; SWG: spring water gargle; ONPS: oronasopharyngeal swab. Note: The two cross symbols for N gene (Ct values of 37 and 38) indicate ONPS samples paired with negative SWG samples on both platforms. The other two targets were not detected from the two ONPS samples that were negative.

References

    1. Howerton E., Ferrari M.J., Bjørnstad O.N., et al. Synergistic interventions to control COVID-19: mass testing and isolation mitigates reliance on distancing. PLoS Comput. Biol. 2021;17(10) doi: 10.1371/journal.pcbi.1009518. - DOI - PMC - PubMed
    1. Zhang J.Y., Bender A.T., Boyle D.S., Drain P.K., Posner J.D. Current state of commercial point-of-care nucleic acid tests for infectious diseases. Analyst. 2021;146(8):2449–2462. doi: 10.1039/d0an01988g. - DOI - PMC - PubMed
    1. Melchers W.J.G., Kuijpers J., Sickler J.J., Rahamat-Langendoen J. Lab-in-a-tube: real-time molecular point-of-care diagnostics for influenza A and B using the cobas® Liat® system. J. Med. Virol. 2017;89(8):1382–1386. doi: 10.1002/jmv.24796. - DOI - PubMed
    1. Tsang H.F., Leung W.M.S., Chan L.W.C., Cho W.C.S., Wong S.C.C. Performance comparison of the Cobas® Liat® and Cepheid® GeneXpert® systems on SARS-CoV-2 detection in nasopharyngeal swab and posterior oropharyngeal saliva. Expert Rev. Mol. Diagn. 2021;21(5):515–518. doi: 10.1080/14737159.2021.1919513. - DOI - PMC - PubMed
    1. Blackall D., Moreno R., Jin J., Plotinsky R., Dworkin R., Oethinger M. Performance Characteristics of the Roche Diagnostics cobas Liat PCR System as a COVID-19 Screening Tool for Hospital Admissions in a Regional Health Care Delivery System. J. Clin. Microbiol. 2021;59(10) doi: 10.1128/JCM.01278-21. - DOI - PMC - PubMed